Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Buckland, P. R. Articles by O’Donovan, M. C. Search for Related Content PubMed Citation Articles by Buckland, P. R. Articles by O’Donovan, M. C. Conventional Neuroleptics Genetics

Low Gene Expression Conferred by Association of an Allele of the 5-HT_2C Receptor Gene With Antipsychotic-Induced Weight Gain

OBJECTIVE: Association has been reported between the C allele of a –759C/T polymorphism in the promoter of the 5-HT_2C receptor gene (HTR2C) and antipsychotic-induced weight gain, suggesting that polymorphic HTR2C expression influences this phenotype. The authors tested this polymorphism, and other promoter variants, for effects on HTR2C transcription. METHOD: Six HTR2C promoter haplotypes constructed from four polymorphisms were cloned into a luciferase reporter gene plasmid. Their transcriptional activities were then compared in two human cell lines. RESULTS: All haplotypes containing the –759C allele showed less transcriptional activity than haplotypes containing the –759T allele. The A allele of a –997G/A polymorphism was also associated with reduced expression. CONCLUSIONS: These findings suggest that the –759C allele is functional and results in relative underexpression of HTR2C. Reduced expression of HTR2C mRNA may underlie vulnerability to weight gain following antipsychotic treatment.

This article has been cited by other articles:

				K. Karunakaran, T. E. Tungaraza, and G. C. Harborne Is clozapine aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia? J Psychopharmacol, June 1, 2007; 21(4): 453 - 456. [Abstract] [PDF]

				G. P. Reynolds, M. J. Hill, and S. L. Kirk The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics J Psychopharmacol, July 1, 2006; 20(4_suppl): 15 - 18. [Abstract] [PDF]

				S. Tighe and T. Dinan An overview of the central control of weight regulation and the effect of antipsychotic medication J Psychopharmacol, November 1, 2005; 19(6_suppl): 36 - 46. [Abstract] [PDF]

				S. C. L. Gough and M. C. O'Donovan Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J Psychopharmacol, November 1, 2005; 19(6_suppl): 47 - 55. [Abstract] [PDF]

				K. J. Miller SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY Mol. Interv., October 1, 2005; 5(5): 282 - 291. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us